KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Labcorp Holdings (LH) over the last 17 years, with Q3 2025 value amounting to $878.0 million.

  • Labcorp Holdings' Accumulated Expenses rose 1590.76% to $878.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $878.0 million, marking a year-over-year increase of 1590.76%. This contributed to the annual value of $871.2 million for FY2024, which is 835.82% up from last year.
  • Labcorp Holdings' Accumulated Expenses amounted to $878.0 million in Q3 2025, which was up 1590.76% from $835.8 million recorded in Q2 2025.
  • In the past 5 years, Labcorp Holdings' Accumulated Expenses ranged from a high of $1.5 billion in Q1 2021 and a low of $649.3 million during Q1 2024
  • For the 5-year period, Labcorp Holdings' Accumulated Expenses averaged around $970.1 million, with its median value being $871.2 million (2024).
  • Its Accumulated Expenses has fluctuated over the past 5 years, first skyrocketed by 8211.57% in 2021, then plummeted by 4394.99% in 2022.
  • Quarter analysis of 5 years shows Labcorp Holdings' Accumulated Expenses stood at $1.4 billion in 2021, then tumbled by 43.95% to $787.0 million in 2022, then increased by 2.16% to $804.0 million in 2023, then grew by 8.36% to $871.2 million in 2024, then rose by 0.78% to $878.0 million in 2025.
  • Its Accumulated Expenses stands at $878.0 million for Q3 2025, versus $835.8 million for Q2 2025 and $770.4 million for Q1 2025.